Ingenito Gary's Form 4 filing
Catalyst Pharmaceuticals, Inc. (CPRX) · filed Jun 23, 2022
- Accession no.
- 0001161697-22-000319
- Filed
- Jun 23, 2022
- Trade date
- Jun 21-22, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $990.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ingenito GaryCIK 0001279473 | Officer (Chief Medical & Reg. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 21, 2022 | Common stock, par value $0.001 per share | MOption exerciseAcquired | +143,848 | $4.13 | +$594,092.24 | 165,901 | Direct | |
| Jun 21, 2022 | Common stock, par value $0.001 per share | SSaleDisposed | −143,848 | $6.60F1,F2 | −$949,396.8 | 22,053 | Direct | |
| Jun 22, 2022 | Common stock, par value $0.001 per share | MOption exerciseAcquired | +6,152 | $4.13 | +$25,407.76 | 28,205 | Direct | |
| Jun 22, 2022 | Common stock, par value $0.001 per share | SSaleDisposed | −6,152 | $6.61F1,F3 | −$40,664.72 | 22,053 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 21, 2022 | Common Stock | MOption exerciseDisposed | −143,848 | $0.00 | $0 | 1,077,819 | Direct | |
| Jun 22, 2022 | Common Stock | MOption exerciseDisposed | −6,152 | $0.00 | $0 | 1,071,667 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Dr. Ingenito sold the shares on the open market for personal reasons and not as a result of any disagreement with the Registrant. Dr. Ingenito remains an officer of the Company.
Referenced by the price of 2 transactions in Table I.
- F2
Shares were sold in various lots from $6.55 to $6.68 per share. The listed sale price represents a weighted average price for the shares sold.
Referenced by the price of 1 transaction in Table I.
- F3
Shares were sold in various lots from $6.55 to $6.71 per share. The listed sale price represents a weighted average price for the shares sold.
Referenced by the price of 1 transaction in Table I.